Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study
- DOI
- 10.1016/j.biopha.2026.119832
- Published
- 2026-09
- Container
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2026.119832,
title = {Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study},
author = {Metka Novak and Bernarda Majc and Marija Skoblar Vidmar and Špela Kladnik and Tina Kolenc Milavec and Anamarija Habič and Simona Katrin Galun and Pia Žižek and Andrej Porčnik and Alenka Matjašič and Andrej Zupan and Miha Jerala and Matic Bošnjak and Borut Prestor and Barbara Breznik Vittori},
year = {2026},
journal = {Biomedicine \& Pharmacotherapy},
doi = {10.1016/j.biopha.2026.119832},
url = {https://doi.org/10.1016/j.biopha.2026.119832}
}RIS
TY - JOUR TI - Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study AU - Metka Novak AU - Bernarda Majc AU - Marija Skoblar Vidmar AU - Špela Kladnik AU - Tina Kolenc Milavec AU - Anamarija Habič AU - Simona Katrin Galun AU - Pia Žižek AU - Andrej Porčnik AU - Alenka Matjašič AU - Andrej Zupan AU - Miha Jerala AU - Matic Bošnjak AU - Borut Prestor AU - Barbara Breznik Vittori PY - 2026 JO - Biomedicine & Pharmacotherapy DO - 10.1016/j.biopha.2026.119832 UR - https://doi.org/10.1016/j.biopha.2026.119832 ER -
APA
Novak, M., Majc, B., Vidmar, M. S., Kladnik, Š., Milavec, T. K., Habič, A., Galun, S. K., Žižek, P., Porčnik, A., Matjašič, A., Zupan, A., Jerala, M., Bošnjak, M., Prestor, B., & Vittori, B. B. (2026). Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2026.119832
Source records
- crossref · retrieved 2026-09-26T19:47:30.678Z